XML 99 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Total
ATM Offering
2018 Underwritten Public Offering
Underwritten Public and Private Offerings
Common Stock
Common Stock
ATM Offering
Common Stock
2018 Underwritten Public Offering
Common Stock
Underwritten Public and Private Offerings
Additional Paid-In Capital
Additional Paid-In Capital
ATM Offering
Additional Paid-In Capital
2018 Underwritten Public Offering
Additional Paid-In Capital
Underwritten Public and Private Offerings
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at Dec. 31, 2017 $ (3,059,537)       $ 13,929       $ 131,492,595         $ (134,566,061)
Balance, shares at Dec. 31, 2017         13,929,763                  
Exercise of stock options 316,767       $ 145       316,622          
Exercise of stock options, shares         144,645                  
Stock-based compensation expense 1,887,764               1,887,764          
Release of restricted stock awards 291       $ 291                  
Release of restricted stock awards, shares         291,010                  
Net share settlement of restricted stock award (150,748)       $ (39)       (150,709)          
Net share settlement of restricted stock award, shares         (38,582)                  
Stock issued under stock purchase plans $ 199,874       $ 82       199,792          
Stock issued under stock purchase plans, shares 2,304       82,261                  
Issuance of common stock   $ 556,706 $ 37,724,316     $ 262 $ 13,915     $ 556,444 $ 37,710,401      
Issuance of common stock, shares           261,352 13,915,000              
Issuance of common stock warrants in connection with MidCap Term Loan $ 74,000               74,000          
Net loss (16,453,918)                         (16,453,918)
Unrealized gain (loss) on short-term investments (2,308)                       $ (2,308)  
Foreign currency translation adjustment (1,145)                       (1,145)  
Balance at Dec. 31, 2018 21,092,062       $ 28,585       172,086,909       (3,453) (151,019,979)
Balance, shares at Dec. 31, 2018         28,585,449                  
Exercise of stock options 120,954       $ 54       120,900          
Exercise of stock options, shares         54,256                  
Stock-based compensation expense 1,156,486               1,156,486          
Release of restricted stock awards 81       $ 81                  
Release of restricted stock awards, shares         81,462                  
Net share settlement of restricted stock award (30,904)       $ (17)       (30,887)          
Net share settlement of restricted stock award, shares         (16,927)                  
Stock issued under stock purchase plans $ 171,190       $ 88       171,102          
Stock issued under stock purchase plans, shares 7,500       87,456                  
Issuance of common stock       $ 20,758,940       $ 29,299       $ 20,729,641    
Issuance of common stock, shares               29,298,537            
Net loss $ (19,297,664)                         (19,297,664)
Unrealized gain (loss) on short-term investments 2,299                       2,299  
Foreign currency translation adjustment (3,810)                       (3,810)  
Balance at Dec. 31, 2019 $ 23,969,634       $ 58,090       $ 194,234,151       $ (4,964) $ (170,317,643)
Balance, shares at Dec. 31, 2019         58,090,233